NCT07472517

AUG 17, 2026 · PHASE 3 TRIAL

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the study is actively recruiting and outcomes have not yet been reported.